MedPath

Effect of Arista Powder on Bleeding in Reductive Mammary Surgery

Phase 2
Completed
Conditions
Mammaplasty
Registration Number
NCT00227084
Lead Sponsor
University of Oslo
Brief Summary

To evaluate whether Arista AH which contains microporous polysaccharides used as a powder applied to the wound area during mammary surgery reduces the amount of bleeding and the duration of surgery. Both mammae are operated on in the same procedure, and one side without Arista serves as control side

Detailed Description

During the operation,before the first incision a randomization envelope is opened. Always starts on the same side, with or without Arista according to the envelope. After surgery, vacuum drains are placed and the amount of drained material and hgb content is measured 24 hours later by nursing staff blinded to what side had Arista.Patients scores postoperative pain with VAS score bilaterally.

Three months postoperatively the patients are checked by a physician blinded for what side had Arista

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • All women for mammary hypertrophy day surgery. No exclusions in this group.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
duration of surgery
amount of bleeding on drain
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ulleval University Hospital

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath